当前位置:首页 - 行情中心 - 蔚蓝生物(603739) - 财务分析 - 现金流量表

蔚蓝生物

(603739)

  

流通市值:32.51亿  总市值:32.51亿
流通股本:2.53亿   总股本:2.53亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金737,143,447.91394,950,690.681,367,328,858.391,049,571,792.13
  收到的税费返还4,164,789.62,931,042.454,267,989.973,639,543.23
  收到其他与经营活动有关的现金29,028,106.157,649,391.3668,489,540.3135,065,700.08
  经营活动现金流入小计770,336,343.66405,531,124.491,440,086,388.671,088,277,035.44
  购买商品、接受劳务支付的现金416,783,881.51215,303,453.73719,269,484.34611,556,132.43
  支付给职工以及为职工支付的现金129,881,024.8576,564,018.33224,215,817.63178,534,315.16
  支付的各项税费51,588,445.422,111,328.15109,454,156.4775,018,002.97
  支付其他与经营活动有关的现金115,788,818.3673,289,735.99273,199,448.84189,411,813.07
  经营活动现金流出小计714,042,170.12387,268,536.21,326,138,907.281,054,520,263.63
  经营活动产生的现金流量净额56,294,173.5418,262,588.29113,947,481.3933,756,771.81
二、投资活动产生的现金流量:
  收回投资收到的现金11,073,189.5911,073,189.59420,000-
  取得投资收益收到的现金--6,302,140.281,212,789.88
  处置固定资产、无形资产和其他长期资产收回的现金净额--255,714.77398,570.39
  处置子公司及其他营业单位收到的现金净额--2,456,090.91-
  收到的其他与投资活动有关的现金258,031,418.9665,600,000915,604,858.96677,910,000
  投资活动现金流入小计269,104,608.5576,673,189.59925,038,804.92679,521,360.27
  购建固定资产、无形资产和其他长期资产支付的现金23,275,306.6414,770,042.9180,009,748.6243,685,575.45
  投资支付的现金--437,500437,500
  取得子公司及其他营业单位支付的现金--3,769,646.31-
  支付其他与投资活动有关的现金235,356,889.03100,195,230915,416,815.12676,911,000
  投资活动现金流出小计258,632,195.67114,965,272.91999,633,710.05721,034,075.45
  投资活动产生的现金流量净额10,472,412.88-38,292,083.32-74,594,905.13-41,512,715.18
三、筹资活动产生的现金流量:
  吸收投资收到的现金--1,730,0001,580,000
  其中:子公司吸收少数股东投资收到的现金--1,730,0001,580,000
  取得借款收到的现金335,703,216.66136,660,015.22752,993,029.39528,973,730.79
  筹资活动现金流入小计335,703,216.66136,660,015.22754,723,029.39530,553,730.79
  偿还债务支付的现金353,397,187.5121,184,343.31716,043,136.98500,087,262.88
  分配股利、利润或偿付利息支付的现金61,992,138.7513,005,518.2476,142,647.860,116,375.82
  其中:子公司支付给少数股东的股利、利润29,666,738.469,300,00033,131,800.0322,571,800.03
  筹资活动现金流出小计415,389,326.25134,189,861.55792,185,784.78560,203,638.7
  筹资活动产生的现金流量净额-79,686,109.592,470,153.67-37,462,755.39-29,649,907.91
四、汇率变动对现金及现金等价物的影响---177,201.94-
五、现金及现金等价物净增加额-12,919,523.17-17,559,341.361,712,618.93-37,405,851.28
  加:期初现金及现金等价物余额235,039,077.25235,039,077.25233,326,458.32233,326,458.32
  期末现金及现金等价物余额222,119,554.08217,479,735.89235,039,077.25195,920,607.04
补充资料:
  净利润53,339,740.57-97,465,510.65-
  资产减值准备86,802.08-6,525,877.88-
  固定资产和投资性房地产折旧48,800,914.23-106,485,295.2-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧48,800,914.23-106,485,295.2-
  无形资产摊销5,825,444.75-10,077,150.25-
  长期待摊费用摊销663,954.37-1,673,816.63-
  处置固定资产、无形资产和其他长期资产的损失-40,678.07--470,744.93-
  固定资产报废损失--26,858.73-
  公允价值变动损失-6,097,810.44--31,643,891.01-
  财务费用7,747,771.57-17,999,067.05-
  投资损失-1,091,181.63-330,637.59-
  递延所得税611,775.04--6,642,788.16-
  其中:递延所得税资产减少572,637.05--6,564,512.19-
    递延所得税负债增加39,137.99--78,275.97-
  存货的减少16,492,141.86--43,944,416.95-
  经营性应收项目的减少-51,323,902.6--47,542,220.91-
  经营性应付项目的增加-23,837,669.42--9,191,770.93-
  现金的期末余额222,119,554.08-235,039,077.25-
  减:现金的期初余额235,039,077.25-233,326,458.32-
  现金及现金等价物的净增加额-12,919,523.17-1,712,618.93-
公告日期2026-08-282026-04-252026-04-252025-10-29
审计意见(境内)标准无保留意见
TOP↑